Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme

Javier R. Revollo, Antje Körner, Kathryn F. Mills, Akiko Satoh, Tao Wang, Antje Garten, Biplab Dasgupta, Yo Sasaki, Cynthia Wolberger, R. Reid Townsend, Jeffrey Milbrandt, Wieland Kiess, Shin ichiro Imai

Research output: Contribution to journalArticle

Abstract

Intracellular nicotinamide phosphoribosyltransferase (iNampt) is an essential enzyme in the NAD biosynthetic pathway. An extracellular form of this protein (eNampt) has been reported to act as a cytokine named PBEF or an insulin-mimetic hormone named visfatin, but its physiological relevance remains controversial. Here we show that eNampt does not exert insulin-mimetic effects in vitro or in vivo but rather exhibits robust NAD biosynthetic activity. Haplodeficiency and chemical inhibition of Nampt cause defects in NAD biosynthesis and glucose-stimulated insulin secretion in pancreatic islets in vivo and in vitro. These defects are corrected by administration of nicotinamide mononucleotide (NMN), a product of the Nampt reaction. A high concentration of NMN is present in mouse plasma, and plasma eNampt and NMN levels are reduced in Nampt heterozygous females. Our results demonstrate that Nampt-mediated systemic NAD biosynthesis is critical for β cell function, suggesting a vital framework for the regulation of glucose homeostasis.

Original languageEnglish (US)
Pages (from-to)363-375
Number of pages13
JournalCell Metabolism
Volume6
Issue number5
DOIs
StatePublished - Nov 7 2007

Fingerprint

Nicotinamide Phosphoribosyltransferase
Nicotinamide Mononucleotide
NAD
Insulin
Enzymes
Glucose
Biosynthetic Pathways
Islets of Langerhans
Homeostasis
Hormones
Cytokines
Proteins

Keywords

  • HUMDISEASE
  • SIGNALING

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Physiology

Cite this

Revollo, J. R., Körner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., ... Imai, S. I. (2007). Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme. Cell Metabolism, 6(5), 363-375. https://doi.org/10.1016/j.cmet.2007.09.003

Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme. / Revollo, Javier R.; Körner, Antje; Mills, Kathryn F.; Satoh, Akiko; Wang, Tao; Garten, Antje; Dasgupta, Biplab; Sasaki, Yo; Wolberger, Cynthia; Townsend, R. Reid; Milbrandt, Jeffrey; Kiess, Wieland; Imai, Shin ichiro.

In: Cell Metabolism, Vol. 6, No. 5, 07.11.2007, p. 363-375.

Research output: Contribution to journalArticle

Revollo, JR, Körner, A, Mills, KF, Satoh, A, Wang, T, Garten, A, Dasgupta, B, Sasaki, Y, Wolberger, C, Townsend, RR, Milbrandt, J, Kiess, W & Imai, SI 2007, 'Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme', Cell Metabolism, vol. 6, no. 5, pp. 363-375. https://doi.org/10.1016/j.cmet.2007.09.003
Revollo, Javier R. ; Körner, Antje ; Mills, Kathryn F. ; Satoh, Akiko ; Wang, Tao ; Garten, Antje ; Dasgupta, Biplab ; Sasaki, Yo ; Wolberger, Cynthia ; Townsend, R. Reid ; Milbrandt, Jeffrey ; Kiess, Wieland ; Imai, Shin ichiro. / Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme. In: Cell Metabolism. 2007 ; Vol. 6, No. 5. pp. 363-375.
@article{94268ebd68784bf59517e178fefc49be,
title = "Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme",
abstract = "Intracellular nicotinamide phosphoribosyltransferase (iNampt) is an essential enzyme in the NAD biosynthetic pathway. An extracellular form of this protein (eNampt) has been reported to act as a cytokine named PBEF or an insulin-mimetic hormone named visfatin, but its physiological relevance remains controversial. Here we show that eNampt does not exert insulin-mimetic effects in vitro or in vivo but rather exhibits robust NAD biosynthetic activity. Haplodeficiency and chemical inhibition of Nampt cause defects in NAD biosynthesis and glucose-stimulated insulin secretion in pancreatic islets in vivo and in vitro. These defects are corrected by administration of nicotinamide mononucleotide (NMN), a product of the Nampt reaction. A high concentration of NMN is present in mouse plasma, and plasma eNampt and NMN levels are reduced in Nampt heterozygous females. Our results demonstrate that Nampt-mediated systemic NAD biosynthesis is critical for β cell function, suggesting a vital framework for the regulation of glucose homeostasis.",
keywords = "HUMDISEASE, SIGNALING",
author = "Revollo, {Javier R.} and Antje K{\"o}rner and Mills, {Kathryn F.} and Akiko Satoh and Tao Wang and Antje Garten and Biplab Dasgupta and Yo Sasaki and Cynthia Wolberger and Townsend, {R. Reid} and Jeffrey Milbrandt and Wieland Kiess and Imai, {Shin ichiro}",
year = "2007",
month = "11",
day = "7",
doi = "10.1016/j.cmet.2007.09.003",
language = "English (US)",
volume = "6",
pages = "363--375",
journal = "Cell Metabolism",
issn = "1550-4131",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme

AU - Revollo, Javier R.

AU - Körner, Antje

AU - Mills, Kathryn F.

AU - Satoh, Akiko

AU - Wang, Tao

AU - Garten, Antje

AU - Dasgupta, Biplab

AU - Sasaki, Yo

AU - Wolberger, Cynthia

AU - Townsend, R. Reid

AU - Milbrandt, Jeffrey

AU - Kiess, Wieland

AU - Imai, Shin ichiro

PY - 2007/11/7

Y1 - 2007/11/7

N2 - Intracellular nicotinamide phosphoribosyltransferase (iNampt) is an essential enzyme in the NAD biosynthetic pathway. An extracellular form of this protein (eNampt) has been reported to act as a cytokine named PBEF or an insulin-mimetic hormone named visfatin, but its physiological relevance remains controversial. Here we show that eNampt does not exert insulin-mimetic effects in vitro or in vivo but rather exhibits robust NAD biosynthetic activity. Haplodeficiency and chemical inhibition of Nampt cause defects in NAD biosynthesis and glucose-stimulated insulin secretion in pancreatic islets in vivo and in vitro. These defects are corrected by administration of nicotinamide mononucleotide (NMN), a product of the Nampt reaction. A high concentration of NMN is present in mouse plasma, and plasma eNampt and NMN levels are reduced in Nampt heterozygous females. Our results demonstrate that Nampt-mediated systemic NAD biosynthesis is critical for β cell function, suggesting a vital framework for the regulation of glucose homeostasis.

AB - Intracellular nicotinamide phosphoribosyltransferase (iNampt) is an essential enzyme in the NAD biosynthetic pathway. An extracellular form of this protein (eNampt) has been reported to act as a cytokine named PBEF or an insulin-mimetic hormone named visfatin, but its physiological relevance remains controversial. Here we show that eNampt does not exert insulin-mimetic effects in vitro or in vivo but rather exhibits robust NAD biosynthetic activity. Haplodeficiency and chemical inhibition of Nampt cause defects in NAD biosynthesis and glucose-stimulated insulin secretion in pancreatic islets in vivo and in vitro. These defects are corrected by administration of nicotinamide mononucleotide (NMN), a product of the Nampt reaction. A high concentration of NMN is present in mouse plasma, and plasma eNampt and NMN levels are reduced in Nampt heterozygous females. Our results demonstrate that Nampt-mediated systemic NAD biosynthesis is critical for β cell function, suggesting a vital framework for the regulation of glucose homeostasis.

KW - HUMDISEASE

KW - SIGNALING

UR - http://www.scopus.com/inward/record.url?scp=35549002189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35549002189&partnerID=8YFLogxK

U2 - 10.1016/j.cmet.2007.09.003

DO - 10.1016/j.cmet.2007.09.003

M3 - Article

C2 - 17983582

AN - SCOPUS:35549002189

VL - 6

SP - 363

EP - 375

JO - Cell Metabolism

JF - Cell Metabolism

SN - 1550-4131

IS - 5

ER -